Provided by Tiger Trade Technology Pte. Ltd.

Vanda Pharmaceuticals

8.82
+1.7925.46%
Post-market: 8.840.0200+0.23%19:59 EST
Volume:23.81M
Turnover:217.17M
Market Cap:521.23M
PE:-6.11
High:9.60
Open:8.53
Low:8.50
Close:7.03
52wk High:9.60
52wk Low:3.81
Shares:59.10M
Float Shares:49.48M
Volume Ratio:13.33
T/O Rate:48.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4426
EPS(LYR):-0.3250
ROE:-16.72%
ROA:-12.15%
PB:1.12
PE(LYR):-27.14

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Oil producers, media stocks, US transport stocks, US airlines

Reuters
·
Yesterday

Vanda Pharmaceuticals Up Over 34%, on Pace for Largest Percent Increase Since November 2013 -- Data Talk

Dow Jones
·
Yesterday

U.S. Stock Movement: Anti-Nausea Drug Nereus Receives FDA Approval, Vanda Pharmaceuticals (VNDA.US) Surges Over 32%

Stock News
·
Dec 31, 2025

These Stocks Are Moving the Most Today: Nvidia, Tesla, Hecla, Newmont, Nike, Vanda, Corcept, DJT, and More -- Barrons.com

Dow Jones
·
Dec 31, 2025

Vanda Pharmaceuticals Inc : B. Riley Raises Target Price to $14 From $11

THOMSON REUTERS
·
Dec 31, 2025

B. Riley Raises Price Target on Vanda Pharmaceuticals to $14 Form $11, Keeps Buy Rating

MT Newswires Live
·
Dec 31, 2025

Vanda Pharmaceuticals Is Maintained at Hold by Jefferies

Dow Jones
·
Dec 31, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Nike, silver and gold miners, Vanda Pharma, Tesla

Reuters
·
Dec 31, 2025

U.S. RESEARCH ROUNDUP-Nextera Energy, Nextpower, TKO Group

Reuters
·
Dec 31, 2025

Vanda Pharmaceuticals Shares up 17.5% Premarket After US FDA Approves Co's Motion Sickness Drug

THOMSON REUTERS
·
Dec 31, 2025

Vanda Pharmaceuticals, One Stop Systems And 3 Stocks To Watch Heading Into Wednesday

Benzinga_recent_news
·
Dec 31, 2025

Why Anghami (ANGH) Shares Soared 50% Overnight?

Benzinga
·
Dec 31, 2025

Vanda Pharmaceuticals Inc : Jefferies Raises Target Price to $7.5 From $5

THOMSON REUTERS
·
Dec 31, 2025

Why Is Vanda Pharmaceuticals' (VNDA) Stock Trending Overnight?

Benzinga
·
Dec 31, 2025

24H|Vanda Pharmaceuticals Jumps 20%; Sable Offshore Gains 5%; Nike up 2%

Tiger Newspress
·
Dec 31, 2025

BRIEF-Vanda Pharmaceuticals Announces FDA Approval Of Nereus (Tradipitant)

Reuters
·
Dec 31, 2025

FDA Approves Vanda Pharmaceuticals' NEREUS for Motion Sickness Prevention

Reuters
·
Dec 31, 2025

Vanda Pharmaceuticals Announces FDA Approval of Nereus™ (Tradipitant) for the Prevention of Vomiting Induced by Motion: a Historic Scientific Milestone in the Prevention of Motion Sickness

THOMSON REUTERS
·
Dec 31, 2025

NASDAQ TRADE HALT HALT NEWS PENDING AT 05:43 PM

Reuters
·
Dec 31, 2025

Top Premarket Gainers

MT Newswires Live
·
Dec 26, 2025